Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT05613894. IPD Sharing: NO. Countries: 1. Publications: 0.
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
ClinicalTrials.gov study NCT02008058. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes
ClinicalTrials.gov study NCT04122976. IPD Sharing: UNDECIDED. Countries: 17. Publications: 0.
A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT00644488. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)
ClinicalTrials.gov study NCT07109414. IPD Sharing: NO. Countries: 1. Publications: 0.
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT04471974. IPD Sharing: NO. Countries: 1. Publications: 0.
Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.
ClinicalTrials.gov study NCT03869762. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment
ClinicalTrials.gov study NCT05627245. IPD Sharing: YES. Countries: 1. Publications: 0.
Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT03230734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)
ClinicalTrials.gov study NCT04055038. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT07164443. IPD Sharing: YES. Countries: 16. Publications: 0.
Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03979508. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Different Resistance Training Intensity Prescription and Monitoring Methodologies: Effects on Strength, Body Composition, and Well-being in Survivors of Breast Cancer
ClinicalTrials.gov study NCT06940310. IPD Sharing: YES. Countries: 1. Publications: 0.
Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study
ClinicalTrials.gov study NCT05960578. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvan
ClinicalTrials.gov study NCT06065748. IPD Sharing: YES. Countries: 37. Publications: 0.
Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Androgen Resistant Metastatic Prostate Cancer
ClinicalTrials.gov study NCT01278914. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancer
ClinicalTrials.gov study NCT01000948. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT05998135. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer
ClinicalTrials.gov study NCT02349139. IPD Sharing: NO. Countries: 1. Publications: 0.
NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer
ClinicalTrials.gov study NCT02429804. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.